col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


46 Results       Page 1

 [1] 
International Research and Cooperation Association for Bio & Socio-Sciences Advancement: Drug Discoveries & Therapeutics
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―21 Examination of the utility of the COVID-19 detection kit, TRC Ready<sup>®</sup> SARS-CoV-2 i for nasopharyngeal swabs Satoru Ishii, Moto Kimura, Tohru Miyoshi-Akiyama, Ataru Moriya, Masami Kurokawa, Erina Isaka, et al. (+5)
2 [GO] 2023―Feb―25 Age distribution and disease severity of COVID-19 patients continued to change in a time-dependent manner from May 2021 to April 2022 in the regional core hospital in Japan Futoshi Kawaura, Takuya Kishi, Tadashi Yamamoto, Shiki Nakayama, Taku Goto, Reimi Tsurusawa, et al. (+11)
3 [GO] 2023―Feb―24 A fast RT-qPCR system significantly shortens the time for SARS-CoV-2 nucleic acid test Hongjie Dong, Kundi Zhang, Junmei Zhang, Yumeng Xiao, Fengyu Zhang, Maofeng Wang, et al. (+7)
4 [GO] 2023―Feb―01 Factors affecting health-related quality of life among firefighters during the COVID-19 pandemic: A single-center study Yukihiro Shigeno, Yukihiro Mori, Kiyoshi Hotta, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, et al. (+4)
5 [GO] 2022―Oct―25 Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial Junko Terada-Hirashima, Manabu Suzuki, Yoshie Tsujimoto, Yoichiro Hamamoto, Yukari Uemura, Kenji Tsushima, et al. (+17)
6 [GO] 2022―Oct―06 Cross-infection risks of SARS-CoV-2 while playing catch using a baseball: Creating a safe sporting environment during the COVID-19 pandemic Yoko Iio, Yukihiro Mori, Masato Tsurudome, Morihiro Ito
7 [GO] 2022―Sep―05 Relaxation of all-case reporting of COVID-19 cases in Japan Kenji Karako
8 [GO] 2022―Aug―20 Prevalence of SARS-CoV-2 antibodies among university athletic club members: A cross-sectional survey Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, et al. (+4)
9 [GO] 2022―Jun―25 Evaluation of Japanese university students' perception of smoking, interest in quitting, and smoking behavior: An examination and public health challenges during the COVID-19 pandemic Makoto Aoike, Yukihiro Mori, Kiyoshi Hotta, Yukihiro Shigeno, Yuka Aoyama, Mamoru Tanaka, et al. (+4)
10 [GO] 2022―Jun―24 Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron era Takehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, Keita Sakamoto, Kohei Takada, Yutaka Muto, et al. (+5)
11 [GO] 2022―May―05 Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? Guangbin Chen, Hongzhou Lu
12 [GO] 2022―Apr―03 Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence Yukihiro Mori, Mamoru Tanaka, Hana Kozai, Kiyoshi Hotta, Yuka Aoyama, Yukihiro Shigeno, et al. (+4)
13 [GO] 2022―Mar―08 Effect of corticosteroids in patients with COVID-19 early stage pneumonia and risk of disease progression: An uncharted territory Anabel Franco-Moreno, María Soledad Acedo-Gutiérrez, Rodolfo Romero-Pareja, Juan Torres-Macho
14 [GO] 2022―Mar―08 Waning COVID-19 vaccine effectiveness in Japan Junko Kurita, Tamie Sugawara, Yasushi Ohkusa
15 [GO] 2022―Mar―08 The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials Basel Abdelazeem, Ahmed K. Awad, Merihan A. Elbadawy, Nouraldeen Manasrah, Bilal Malik, Amman Yousaf, et al. (+3)
16 [GO] 2022―Jan―14 Drug discovery to treat COVID-19 two years after its outbreak Jianjun Gao, Fusheng Sun
17 [GO] 2022―Jan―14 Pneumothorax and pneumomediastinum in patients with COVID-19: A retrospective study from tertiary care institute in India Saurav Sekhar Paul, Bhavesh Mohan Lal, Animesh Ray, Ved Prakash Meena, Rohit Kumar Garg, Pawan Tiwari, et al. (+6)
18 [GO] 2021―Dec―29 Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review Yayun Xu, Li Yang, Longfei Wang, Feihu Chen
19 [GO] 2021―Oct―29 Post COVID-19 sequelae: A prospective observational study from Northern India Shivdas Naik, Soumendra Nath Haldar, Manish Soneja, Netto George Mundadan, Prerna Garg, Ankit Mittal, et al. (+22)
20 [GO] 2021―Oct―27 Role of systemic corticosteroids in preventing hypoxia among patients with mild COVID-19: An observational study Anivita Aggarwal, Ankit Mittal, Manish Soneja, Sujay Halkur Shankar, Shivdas Naik, Parul Kodan, et al. (+4)
21 [GO] 2021―Oct―27 Antiviral effect of electrolyzed reduced water on SARS-CoV-2 Yoshinao Okajima, Masahiro Okajima, Mitsuo Ikeda, Yuko Wada, Ken-ichi Shimokawa, Fumiyoshi Ishii
22 [GO] 2021―Oct―25 Does immunosuppressive property of non-steroidal anti-inflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects? Itsuro Kazama, Momono Senzaki
23 [GO] 2021―Aug―25 India and management of COVID-19: A case study on published guidelines Rohit Kumar, Ankit Mittal, Shreya Das Adhikari, Eram Afroz, Nitin Gupta
24 [GO] 2021―Jul―18 Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021 Cui Xiaoni, Wang Pengxiang, Wei Zhun
25 [GO] 2021―Jul―05 Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19 Qian Li, Jun Wang, Yang Tang, Hongzhou Lu
26 [GO] 2021―Jul―05 Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India Neha Chopra, Mohit Chowdhury, Anupam K Singh, Khan MA, Arvind Kumar, Piyush Ranjan, et al. (+2)
27 [GO] 2021―Jul―05 Antimicrobial resistance and COVID-19 syndemic: Impact on public health Ashima Jain Vidyarthi, Arghya Das, Rama Chaudhry
28 [GO] 2021―Feb―27 Clinical profile and outcomes of asymptomatic vs. symptomatic travellers diagnosed with COVID-19: An observational study from a coastal town in South India Nitin Gupta, Anupa John, Mohammed Safeer Kokkottil, Muralidhar Varma, Shashikiran Umakanth, Kavitha Saravu
29 [GO] 2021―Feb―18 Multidrug treatment for COVID-19 Masashi Ohe, Ken Furuya, Houman Goudarzi
30 [GO] 2020―Dec―30 Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2 Ines ElBini Dhouib
31 [GO] 2020―Dec―29 COVID-19 in patients living with human immunodeficiency virus (HIV) infection: Challenges and way-forward Manasvini Bhatt, Manish Soneja, Nitin Gupta
32 [GO] 2020―Dec―29 Approach to acute febrile illness during the COVID-19 pandemic Manasvini Bhatt, Manish Soneja, Nitin Gupta
33 [GO] 2020―Dec―29 Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic Yaser Pashaei
34 [GO] 2020―Oct―28 Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis? Mir S. Adil, S. Priya Narayanan, Payaningal R. Somanath
35 [GO] 2020―Sep―07 Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19 Shweta Sinha, Alka Sehgal, Rakesh Sehgal
36 [GO] 2020―Sep―07 Laboratory diagnosis of COVID-19 in Africa: availability, challenges and implications Elijah Kolawole Oladipo, Ayodeji Folorunsho Ajayi, Aduragbemi Noah Odeyemi, Olawumi Elizabeth Akindiya, Emmanuel Tayo Adebayo, Ayomide Samuel Oguntomi, et al. (+6)
37 [GO] 2020―Sep―07 Review of current clinical management guidelines for COVID-19 with special reference to India Rohit Kumar, Kutty Sharada Vinod, Ankit Mittal, Shreya Das Adhikari, Nitin Gupta
38 [GO] 2020―Jul―14 Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies Bushra Hassan Marouf, Kawa Dizaye
39 [GO] 2020―Jul―14 Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research Jinjing Wang, Fanghua Qi
40 [GO] 2020―Jun―24 Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? Itsuro Kazama
41 [GO] 2020―Jun―15 Can mesenchymal stem cell therapy be the interim management of COVID-19? Chitra Bamba, Surinder P. Singh, Sangeeta Choudhury
42 [GO] 2020―May―05 Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far? Yuanyuan Zhang, Yanyan Zhong, Lin Pan, Jing Dong
43 [GO] 2020―Apr―24 Treatment of SARS-CoV-2: How far have we reached? Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, Hassan A. Alhazmi, Asim Najmi
44 [GO] 2020―Apr―20 Is GSK3β a molecular target of chloroquine treatment against COVID-19? Mohammed Noor Embi, Nagesswary Ganesan, Hasidah Mohd Sidek
45 [GO] 2020―Mar―25 Facts and reflections on COVID-19 and anti-hypertensives drugs Gustavo H. Marin
46 [GO] 2020―Mar―07 Discovering drugs to treat coronavirus disease 2019 (COVID-19) Liying Dong, Shasha Hu, Jianjun Gao
 [1] 

46 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.010 sec